U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07222410) titled 'Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital' on Oct. 23.
Brief Summary: The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain patients' SpO2 levels within the target range better than manual oxygen titration in hospitalized COPD patients with hypoxemia/respiratory distress.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition: 
COPD
Intervention: 
DEVICE: Closed loop oxygen control
Nasal high flow with closed loop oxygen control
DEVICE: Manual titration
Nasal high flow with manual titration
Recruitmen...
		
			